Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 359

1.

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.

Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D.

Parkinsonism Relat Disord. 2009 Mar;15(3):226-31. doi: 10.1016/j.parkreldis.2008.05.006. Epub 2008 Jul 2.

PMID:
18595765
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D.

J Am Geriatr Soc. 2009 Feb;57(2):304-8. doi: 10.1111/j.1532-5415.2008.02096.x. Epub 2008 Dec 10.

PMID:
19170786
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.

Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT.

Parkinsonism Relat Disord. 2013 Sep;19(9):806-11. doi: 10.1016/j.parkreldis.2013.05.006. Epub 2013 Jun 2.

PMID:
23735187
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Characterizing mild cognitive impairment in Parkinson's disease.

Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ.

Mov Disord. 2011 Mar;26(4):629-36. doi: 10.1002/mds.23592. Epub 2011 Feb 1.

PMID:
21287603
[PubMed - indexed for MEDLINE]
5.

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C.

Mov Disord. 2008 Jan 30;23(2):297-9.

PMID:
18044697
[PubMed - indexed for MEDLINE]
6.

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G; Norwegian ParkWest Study Group.

Neurology. 2009 Mar 31;72(13):1121-6. doi: 10.1212/01.wnl.0000338632.00552.cb. Epub 2008 Nov 19.

PMID:
19020293
[PubMed - indexed for MEDLINE]
7.

Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA.

Pendlebury ST, Markwick A, de Jager CA, Zamboni G, Wilcock GK, Rothwell PM.

Cerebrovasc Dis. 2012;34(1):48-54. doi: 10.1159/000338905. Epub 2012 Jun 29.

PMID:
22759627
[PubMed - indexed for MEDLINE]
Free Article
8.

Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.

Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A.

J Neural Transm. 2013 Apr;120(4):627-33. doi: 10.1007/s00702-013-1004-2. Epub 2013 Mar 13.

PMID:
23483334
[PubMed - indexed for MEDLINE]
9.

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D.

Neurology. 2009 Nov 24;73(21):1738-45. doi: 10.1212/WNL.0b013e3181c34b47.

PMID:
19933974
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.

Song IU, Kim JS, Jeong DS, Song HJ, Lee KS.

Parkinsonism Relat Disord. 2008 Nov;14(7):558-62. doi: 10.1016/j.parkreldis.2008.01.007. Epub 2008 Mar 6.

PMID:
18328767
[PubMed - indexed for MEDLINE]
11.

Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU.

J Neurol. 2008 Feb;255(2):255-64. doi: 10.1007/s00415-008-0720-2. Epub 2008 Jan 22.

PMID:
18204803
[PubMed - indexed for MEDLINE]
12.

Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG.

Mov Disord. 2012 Aug;27(9):1129-36. doi: 10.1002/mds.25062. Epub 2012 Jul 6.

PMID:
22778009
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Defining mild cognitive impairment in Parkinson's disease.

Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH.

Mov Disord. 2007 Jul 15;22(9):1272-7.

PMID:
17415797
[PubMed - indexed for MEDLINE]
14.

The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease.

Caslake R, Summers F, McConachie D, Ferris C, Gordon J, Harris C, Caie L, Counsell C.

Curr Aging Sci. 2013 Dec;6(3):273-9.

PMID:
23773030
[PubMed - indexed for MEDLINE]
15.

Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.

Hanna-Pladdy B, Enslein A, Fray M, Gajewski BJ, Pahwa R, Lyons KE.

Int J Neurosci. 2010 Aug;120(8):538-43. doi: 10.3109/00207454.2010.496539.

PMID:
20615057
[PubMed - indexed for MEDLINE]
16.

CERAD test performance and cognitive impairment in Parkinson's disease.

Karrasch M, Laatu S, Martikainen K, Marttila R.

Acta Neurol Scand. 2013 Dec;128(6):409-13. doi: 10.1111/ane.12138. Epub 2013 May 14.

PMID:
23668316
[PubMed - indexed for MEDLINE]
17.

Measuring mild cognitive impairment in patients with Parkinson's disease.

Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Duff-Canning S.

Mov Disord. 2013 May;28(5):626-33. doi: 10.1002/mds.25426. Epub 2013 Mar 20.

PMID:
23520128
[PubMed - indexed for MEDLINE]
18.

The pill questionnaire in a nondemented Parkinson's disease population.

Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, Mast B, Marras C.

Mov Disord. 2012 Sep 1;27(10):1308-11. doi: 10.1002/mds.25124. Epub 2012 Aug 1.

PMID:
22865587
[PubMed - indexed for MEDLINE]
19.

MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.

Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM.

Stroke. 2012 Feb;43(2):464-9. doi: 10.1161/STROKEAHA.111.633586. Epub 2011 Dec 8.

PMID:
22156700
[PubMed - indexed for MEDLINE]
Free Article
20.

Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT.

Mov Disord. 2013 Dec;28(14):1972-9. doi: 10.1002/mds.25655. Epub 2013 Oct 9.

PMID:
24123267
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk